2017
DOI: 10.1016/j.bpa.2017.01.004
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacogenetics in obstetric anesthesia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 69 publications
0
2
1
Order By: Relevance
“…Our findings with respect to the effect of the five gene polymorphisms on the intra-operative remifentanil and propofol consumption were less promising, even though it is perhaps worth mentioning that all four carriers of the OPRM1 118GG genotype consumed low amounts of remifentanil, and so did five out of six patients with the CYP2B6 516TT genotype with respect to propofol. A small number of studies have examined the association of the same OPRM1 polymorphism with intra-operative opioid (fentanyl, sulfentanil, or morphine) requirements, all of them involving obstetrics analgesia [reviewed in [ 31 ], and in [ 32 ], with inconclusive results, even though carriage of the G allele appeared to somewhat increase opioid efficacy, which is not contradictory to our findings. According to our literature search, no study has examined the effect of OPRM1 A118G on remifentanil requirements thus far, with the exception of a single report highlighting a protective effect of the maternal G allele on neonates whose mothers had received remifentanil in the context of labor anesthesia [ 15 ].…”
Section: Discussioncontrasting
confidence: 43%
“…Our findings with respect to the effect of the five gene polymorphisms on the intra-operative remifentanil and propofol consumption were less promising, even though it is perhaps worth mentioning that all four carriers of the OPRM1 118GG genotype consumed low amounts of remifentanil, and so did five out of six patients with the CYP2B6 516TT genotype with respect to propofol. A small number of studies have examined the association of the same OPRM1 polymorphism with intra-operative opioid (fentanyl, sulfentanil, or morphine) requirements, all of them involving obstetrics analgesia [reviewed in [ 31 ], and in [ 32 ], with inconclusive results, even though carriage of the G allele appeared to somewhat increase opioid efficacy, which is not contradictory to our findings. According to our literature search, no study has examined the effect of OPRM1 A118G on remifentanil requirements thus far, with the exception of a single report highlighting a protective effect of the maternal G allele on neonates whose mothers had received remifentanil in the context of labor anesthesia [ 15 ].…”
Section: Discussioncontrasting
confidence: 43%
“…A genetic basis for propensity to hypotension has also been proposed. [ 5 ] Recently, ondansetron has been shown to minimise the incidence of hypotension and bradycardia by inhibiting the Bezold--Jarisch reflex. The effect was only moderate (NNT of 5.3 and 7.6 for preventing hypotension and bradycardia).…”
Section: Discussionmentioning
confidence: 99%
“…16 Candidate gene studies focusing on labor pain have been undertaken with associative findings in ADRB2 (β2-andrenergic receptor), OPRM1 (µ-opioid receptor), and GCH1 (guanosine triphosphate cyclohydrolase). 17…”
Section: Introductionmentioning
confidence: 99%